ISRCTN34455240已完成不适用
Misoprostol to treat Postpartum Haemorrhage (PPH): a randomised controlled trial (Argentina, Egypt, South Africa, Thailand and Viet Nam)
DP/UNFPA/WHO/World Bank - Special Programme of Research, Development and Research Training in Human Reproduction0 个研究点目标入组 1,400 人开始时间: 2005年6月7日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 1,400
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Female
入选标准
- •All women delivering vaginally with clinically diagnosed PPH thought to be due to or contributed to by atonia requiring additional uterotonics will receive either misoprostol or placebo in addition to routine treatment for PPH.
排除标准
- •Refusal to give consent for participation; Too ill or distressed to give consent; The woman is not entitled to give informed consent e.g. minors without a guardian; The delivery is regarded as abortion according to the local gestational age limits; If the woman is delivered by caesarean section; If the woman cannot take misoprostol sub-lingually; If the woman suffers from severe bleeding disorder such as haemophilia; If the woman has a temperature of more than 38.5°C; If the woman has any severe allergic condition; If the woman's placenta is not delivered at the time of randomization.
研究者
相似试验
已完成
不适用
Misoprostol for treating postpartum haemorrhage: a randomised controlled trialPostpartum haemorrhagePregnancy and ChildbirthISRCTN72263357niversity of the Witwatersrand (South Africa)
已完成
不适用
Misoprostol in the Treatment of Postpartum HemorrhagePostpartum HemorrhageNCT00116480Gynuity Health Projects61
已完成
2 期
Oral Misoprostol Versus Intravenous Oxytocin in Preventing Blood Loss After Non-scheduled Cesarean SectionPostpartum HemorrhageNCT00107874University Hospital, Basel, Switzerland56
已完成
不适用
Misoprostol for Treatment of Postpartum Haemorrhage (PPH) in Home BirthsPostpartum Hemorrhage (PPH)NCT01508429Gynuity Health Projects70
已完成
不适用
Misoprostol for Preventing Postpartum HemorrhagePostpartum HemorrhageNCT00124540Gynuity Health Projects1,200